Arthur Cox is very pleased to partner with Paul, Weiss, Rifkind, Wharton & Garrison LLP in advising PRA Health Sciences on its proposed acquisition by ICON plc in a cash and stock transaction valued at approximately $12 billion, creating a world leader in healthcare intelligence and clinical research.

The Arthur Cox team was led by Cian McCourt (Corporate and M&A) and included Aaron Vickery and Reem Ka’ati (Corporate and M&A), Fintan Clancy, Orlaith Kane and Nicola Cavey (Tax), Cian Beecher and Ailbhe Moloney (Employment), Colin Kavanagh and Bridget McGrath (Regulatory), Olivia Mullooly and Eoghan Clogher (Technology and Innovation), Patrick Horan and Simon Breen (Competition and Regulated Markets).

Read more here.